ID   HKBML
AC   CVCL_8161
DR   CLO; CLO_0050638
DR   BioSample; SAMN03472185
DR   RCB; RCB0820
DR   Wikidata; Q54889741
RX   PubMed=30993483;
RX   PubMed=31510952;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): RCB=RCB0820
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,12
ST   D16S539: 9,13
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 14,17
DI   NCIt; C9301; Central nervous system lymphoma
DI   ORDO; Orphanet_46135; Primary central nervous system lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
RX   PubMed=30993483; DOI=10.1007/s10147-019-01451-9;
RA   Hayano A., Takashima Y., Yamanaka R.;
RT   "Cell-type-specific sensitivity of bortezomib in the
RT   methotrexate-resistant primary central nervous system lymphoma
RT   cells.";
RL   Int. J. Clin. Oncol. 24:1020-1029(2019).
//
RX   PubMed=31510952; DOI=10.1186/s12885-019-6129-8; PMCID=PMC6739943;
RA   Takashima Y., Yoshimura T., Kano Y., Hayano A., Hondoh H., Ikenaka K.,
RA   Yamanaka R.;
RT   "Differential expression of N-linked oligosaccharides in
RT   methotrexate-resistant primary central nervous system lymphoma
RT   cells.";
RL   BMC Cancer 19:910.1-910.11(2019).
//